Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II

In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regula...

Full description

Bibliographic Details
Main Authors: Andrea Salzano, Domenico Sirico, Michele Arcopinto, Alberto Maria Marra, Germano Guerra, Aldo Rocca, Alessandra Grieco, Francesco Giallauria, Carlo Vigorito
Format: Article
Language:English
Published: PAGEPress Publications 2015-11-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/64
_version_ 1828874451679182848
author Andrea Salzano
Domenico Sirico
Michele Arcopinto
Alberto Maria Marra
Germano Guerra
Aldo Rocca
Alessandra Grieco
Francesco Giallauria
Carlo Vigorito
author_facet Andrea Salzano
Domenico Sirico
Michele Arcopinto
Alberto Maria Marra
Germano Guerra
Aldo Rocca
Alessandra Grieco
Francesco Giallauria
Carlo Vigorito
author_sort Andrea Salzano
collection DOAJ
description In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro- RNA, post-translational modification and microspheres based therapy.
first_indexed 2024-12-13T07:37:24Z
format Article
id doaj.art-7bba699c23a84128bdbf091ce89d8847
institution Directory Open Access Journal
issn 1122-0643
2532-5264
language English
last_indexed 2024-12-13T07:37:24Z
publishDate 2015-11-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj.art-7bba699c23a84128bdbf091ce89d88472022-12-21T23:55:02ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642015-11-0182410.4081/monaldi.2014.64Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part IIAndrea Salzano0Domenico Sirico1Michele Arcopinto2Alberto Maria Marra3Germano Guerra4Aldo Rocca5Alessandra Grieco6Francesco Giallauria7Carlo Vigorito8Department of Traslational Medical Sciences, University Federico II, NaplesDepartment of Traslational Medical Sciences, University Federico II, NaplesDepartment of Cardiac Surgery, IRCCS Policlinico San Donato, MilanDepartment of Traslational Medical Sciences, University Federico II, NaplesDepartment of Medicine and Health Sciences, University of Molise, CampobassoDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, NaplesDepartment of Traslational Medical Sciences, University Federico II, NaplesDepartment of Traslational Medical Sciences, University Federico II, NaplesDepartment of Traslational Medical Sciences, University Federico II, NaplesIn recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro- RNA, post-translational modification and microspheres based therapy.https://www.monaldi-archives.org/index.php/macd/article/view/64cardiac remodelinggene therapystem cellsmicro-RNAmicrospheresheart failure.
spellingShingle Andrea Salzano
Domenico Sirico
Michele Arcopinto
Alberto Maria Marra
Germano Guerra
Aldo Rocca
Alessandra Grieco
Francesco Giallauria
Carlo Vigorito
Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
Monaldi Archives for Chest Disease
cardiac remodeling
gene therapy
stem cells
micro-RNA
microspheres
heart failure.
title Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
title_full Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
title_fullStr Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
title_full_unstemmed Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
title_short Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
title_sort anti remodeling therapy new strategies and future perspective in post ischemic heart failure part ii
topic cardiac remodeling
gene therapy
stem cells
micro-RNA
microspheres
heart failure.
url https://www.monaldi-archives.org/index.php/macd/article/view/64
work_keys_str_mv AT andreasalzano antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT domenicosirico antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT michelearcopinto antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT albertomariamarra antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT germanoguerra antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT aldorocca antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT alessandragrieco antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT francescogiallauria antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii
AT carlovigorito antiremodelingtherapynewstrategiesandfutureperspectiveinpostischemicheartfailurepartii